Skip to main content
SpringerLink
Log in

Erectile Dysfunction: Prevalence and Pathophysiology

  • Chapter
  • First Online:
Cancer and Sexual Health

Part of the book series: Current Clinical Urology ((CCU))

  • 1576 Accesses

Abstract

It was roughly 20 years ago when, in 1993, the US National Institutes of Health panel on impotence developed the rigorous definition for erectile dysfunction (ED), which was then described as the persistent inability to attain and/or maintain a penile erection sufficient to complete a satisfactory sexual intercourse [1]. In this context, a 3-month duration has been considered the minimum length of time necessary for actual establishment of the diagnosis, except in some instances of traumatic or surgically induced ED.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 219.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 279.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. NIH. Consensus development panel on impotence. JAMA. 1993;270:83–90.

    Google Scholar 

  2. US Renal Data System, USRDS. 2006 annual data report: atlas of end-stage renal. Disease in the United States. Bethesda: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2006.

    Google Scholar 

  3. Slob AK. Age, libido, and male sexual function. Prostate Suppl. 2000;10:9–13.

    PubMed  CAS  Google Scholar 

  4. Kinsey AC, Pomeroy PW, Martin CE. Age and sexual outlet. In: Kinsey AC, Pomeroy WB, Martin CE, editors. Sexual behaviour in the human male. Philadelphia: WB Saunders; 1948.

    Google Scholar 

  5. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994;151:54–61.

    PubMed  CAS  Google Scholar 

  6. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA. 1999;281:537–44.

    PubMed  CAS  Google Scholar 

  7. Saigal CS, Wessells H, Pace J, Schonlau M, Wilt TJ. Predictors and prevalence of erectile dysfunction in a racially diverse population. Arch Intern Med. 2006;166:207–12.

    PubMed  Google Scholar 

  8. Porst H, Buvat J, editors. Standard practice in sexual medicine. Malden: Blackwell Publishing; 2006.

    Google Scholar 

  9. Braun M, Klots T, Reifenrath B, et al. Die Prävalenz von männlichen Erektionsstörungen in Deutschland heute und in der Zukunft. Akt Urol. 2000;31:302–7.

    Google Scholar 

  10. Chew KK, Earle CM, Stuckey BGA, et al. Erectile dysfunction in general medicine practice: prevalence and clinical correlates. Int J Impot Res. 2000;12:41–5.

    PubMed  CAS  Google Scholar 

  11. Meuleman E, Kolman D, Donkers L, et al. Male erectile dysfunction: prevalence and quality of life in the Netherlands: the EREPIC-study. Int J Impot Res. 2000;12 Suppl 5:S8; abstract P28.

    Google Scholar 

  12. Mahmoud KZ, Azim SA, Gadallah M, et al. A patient based epidemiology study to find the prevalence and correlates of erectile dysfunction in Egypt. Int J Impot Res. 2000;12 Suppl 5:S24; abstract P46.

    Google Scholar 

  13. Koskimaki J, Hakama M, Tammela TLJ. Prevalence of erectile dysfunction in Finland. Int J Impot Res. 2000;12 Suppl 5:S25; abstract P47.

    Google Scholar 

  14. Kadiri N, Barrada S, Tahiri S, et al. Prevalence of erectile dysfunction and its correlates in Morocco: a population based epidemiology study. Int J Impot Res. 2000;12 Suppl 5:S25; abstract P48.

    Google Scholar 

  15. Martin-Morales A, Sanchez-Cruz JJ, Saenz de Tajada I, et al. Prevalence and independent risk factors for erectile dysfunction in Spain. Results of the Epidemiologia de la Disfuncion Erectil Masculina Study. J Urol. 2001;166:569–74.

    PubMed  CAS  Google Scholar 

  16. Rosen RC, Fisher WA, Eardley I, et al. The multinational Men’s Attitudes to Life Events and Sexuality (MALES) study: I. Prevalence of erectile dysfunction and related health concerns in the general population. Curr Med Res Opin. 2004;20:607–17.

    PubMed  Google Scholar 

  17. De Boer BJ, Bots ML, Lycklama a Nijeholt AAB, et al. Erectile dysfunction in primary care: relevance and patient characteristics. The ENIGMA study. Int J Impot Res. 2004;16:358–64.

    PubMed  Google Scholar 

  18. Ponholzer A, Temml C, Mock K, et al. Prevalence and risk factors for erectile dysfunction in 2869 men using a validated questionnaire. Eur Urol. 2005;47:80–6.

    PubMed  Google Scholar 

  19. Glina S, Melo LF, Martins FG, et al. Brazilian survey on aging and sexual performance. 9th world meeting on impotence research, Perth. Int J Impot Res. 2000;12:55; abstract M58.

    Google Scholar 

  20. Selvin E, Burnett AL, Platz EA. Prevalence and risk factors for erectile dysfunction in the US. Am J Med. 2007;120:151–7.

    PubMed  Google Scholar 

  21. Grover SA, Lowensteyn I, Kaouache M, et al. The prevalence of erectile dysfunction in the primary care setting: importance of risk factors for diabetes and vascular disease. Arch Intern Med. 2006;166:213–9.

    PubMed  Google Scholar 

  22. Rosen RC, Riley A, Wagner G, et al. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997;49:822–30.

    PubMed  CAS  Google Scholar 

  23. United States Bureau of the Census. Statistical abstract of the United States 1992. Washington: USBC; 1992.

    Google Scholar 

  24. United States Bureau of the Census. Historical statistics of the United States, colonial times to 1970. Bicentennial edition. Part 2. Washington: USBC; 1975.

    Google Scholar 

  25. Salonia A, Briganti A, Dehò F, et al. Pathophysiology of erectile dysfunction. Int J Androl. 2003;26:129–36.

    PubMed  Google Scholar 

  26. Andersson KE, Wagner G. Physiology of penile erection. Physiol Rev. 1995;75:191–236.

    PubMed  CAS  Google Scholar 

  27. Giuliano F, Rampin O, Benoit G, et al. Neural control of penile erection. Urol Clin North Am. 1995;22:747–60.

    PubMed  CAS  Google Scholar 

  28. Montorsi F, Maga T, Strambi LF, et al. Sildenafil taken at bedtime significantly increases nocturnal erections: results of a placebo-controlled study. Urology. 2000;56:906–11.

    PubMed  CAS  Google Scholar 

  29. Tarcan T, Azadzoi KM, Siroky MB, Goldstein I, Krane RJ. Age-related erectile and voiding dysfunction: the role of arterial insufficiency. Br J Urol. 1998;82 Suppl 1:26–33.

    PubMed  Google Scholar 

  30. Moreland RB. Is there a role of hypoxemia in penile fibrosis: a viewpoint presented to the Society for the Study of Impotence. Int J Impot Res. 1998;10:113–20.

    PubMed  CAS  Google Scholar 

  31. Benet AE, Melman A. The epidemiology of erectile dysfunction. Urol Clin North Am. 1995;22:699–709.

    PubMed  CAS  Google Scholar 

  32. Corona G, Mannucci E, Forti G, Maggi M. Hypogonadism, ED, metabolic syndrome and obesity: a pathological link supporting cardiovascular diseases. Int J Androl. 2009;32:587–98.

    PubMed  CAS  Google Scholar 

  33. Schoneich C. Reactive oxygen species and biological aging: a mechanistic approach. Exp Gerontol. 1999;34:19–34.

    PubMed  CAS  Google Scholar 

  34. Rossi A, Ganassini A, Tantucci C, Grassi V. Aging and the respiratory system. Aging (Milano). 1996;8:143–61.

    CAS  Google Scholar 

  35. Bitar KN. Aging and neural control of the GI tract: V. Aging and gastrointestinal smooth muscle: from signal transduction to contractile proteins. Am J Physiol Gastrointest Liver Physiol. 2003;284:G1–7.

    PubMed  CAS  Google Scholar 

  36. Al-Shaer MH, Choueiri NE, Correia ML, Sinkey CA, Barenz TA, Haynes WG. Effects of aging and atherosclerosis on endothelial and vascular smooth muscle function in humans. Int J Cardiol. 2006;109:201–6.

    PubMed  Google Scholar 

  37. McVary K. Lower urinary tract symptoms and sexual dysfunction: epidemiology and pathophysiology. BJU Int. 2006;97 Suppl 2:23–8. discussion 44–5.

    PubMed  Google Scholar 

  38. Taub HC, Lerner SE, Melman A, Christ GJ. Relationship between contraction and relaxation in human and rabbit corpus cavernosum. Urology. 1993;42:698–704.

    PubMed  CAS  Google Scholar 

  39. Saenz de Tejada I, Carson MP, de las Morenas A, Goldstein I, Traish AM. Endothelin: localization, synthesis, activity, and receptor types in human penile corpus cavernosum. Am J Physiol. 1991;261:H1078–85.

    PubMed  CAS  Google Scholar 

  40. Burnett AL. Role of nitric oxide in the physiology of erection. Biol Reprod. 1995;52:485–9.

    PubMed  CAS  Google Scholar 

  41. Garban H, Vernet D, Freedman A, Rajfer J, Gonzalez-Cadavid N. Effect of aging on nitric oxide-mediated penile erection in rats. Am J Physiol. 1995;268:H467–75.

    PubMed  CAS  Google Scholar 

  42. Carrier S, Nagaraju P, Morgan DM, Baba K, Nunes L, Lue TF. Age decreases nitric oxide synthase-containing nerve fibers in the rat penis. J Urol. 1997;157:1088–92.

    PubMed  CAS  Google Scholar 

  43. Dahiya R, Chui R, Perinchery G, Nakajima K, Oh BR, Lue TF. Differential gene expression of growth factors in young and old rat penile tissues is associated with erectile dysfunction. Int J Impot Res. 1999;11:201–6.

    PubMed  CAS  Google Scholar 

  44. Rajasekaran M, Kasyan A, Jain A, Kim SW, Monga M. Altered growth factor expression in the aging penis: the Brown–Norway rat model. J Androl. 2002;23:393–9.

    PubMed  CAS  Google Scholar 

  45. Chitaley K, Wingard CJ, Webb R, et al. Antagonism of Rho-kinase stimulates rat penile erection via a nitric oxide-independent pathway. Nat Med. 2001;7:119–22.

    PubMed  CAS  Google Scholar 

  46. Wang H, Eto M, Steers WD, Somlyo AP, Somlyo AV. RhoA-mediated Ca2+ sensitization in erectile function. J Biol Chem. 2002;277:30614–21.

    PubMed  CAS  Google Scholar 

  47. Somlyo AP, Somlyo AV. Signal transduction by Gproteins, rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II. J Physiol. 2000;522:177–85.

    PubMed  CAS  Google Scholar 

  48. Miao L, Calvert JW, Tang J, Parent AD, Zhang JH. Age-related RhoA expression in blood vessels of rats. Mech Ageing Dev. 2001;122:1757–70.

    PubMed  CAS  Google Scholar 

  49. Dusing R. Sexual dysfunction in male patients with hypertension: influence of antihypertensive drugs. Drugs. 2005;65:773–86.

    PubMed  Google Scholar 

  50. Heruti RJ, Sharabi Y, Arbel Y, et al. The prevalence of erectile dysfunction among hypertensive and prehypertensive men aged 25–40 years. J Sex Med. 2007;4:596–601.

    PubMed  Google Scholar 

  51. Lee DL, Webb RC, Jin L. Hypertension and RhoA/Rho-kinase signaling in the vasculature: highlights from the recent literature. Hypertension. 2004;44:796–9.

    PubMed  CAS  Google Scholar 

  52. Wilkes N, White S, Stein P, Bernie J, Rajasekaran M. Phosphodiesterase-5 inhibition synergizes rhokinase antagonism and enhances erectile response in male hypertensive rats. Int J Impot Res. 2004;16:187–94.

    PubMed  CAS  Google Scholar 

  53. Wingard CJ, Johnson JA, Holmes A, Prikosh A. Improved erectile function after Rho-kinase inhibition in a rat castrate model of erectile dysfunction. Am J Physiol Regul Integr Comp Physiol. 2003;284:R1572–9.

    PubMed  CAS  Google Scholar 

  54. The French Study of Aortic Plaques in Stroke Group. Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke. N Engl J Med. 1996;334:1216–21.

    Google Scholar 

  55. Meissner I, Khandheria BK, Sheps SG, et al. Atherosclerosis of the aorta: risk factor, risk marker, or innocent bystander? A prospective populationbased transesophageal echocardiography study. J Am Coll Cardiol. 2004;44:1018–24.

    PubMed  Google Scholar 

  56. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation. 2006;113:463–654.

    Google Scholar 

  57. Montorsi P, Montorsi F, Schulman CC. Is erectile dysfunction the “tip of the iceberg” of a systemic vascular disorder? Eur Urol. 2003;44:352–4.

    PubMed  Google Scholar 

  58. Azadzoi KM, Tarcan T, Siroky MB, Krane RJ. Atherosclerosis-induced chronic ischemia causes bladder fibrosis and non-compliance in the rabbit. J Urol. 1999;161:1626–35.

    PubMed  CAS  Google Scholar 

  59. Montorsi F, Briganti A, Salonia A, et al. The ageing male and erectile dysfunction. BJU Int. 2003;92:516–20.

    PubMed  CAS  Google Scholar 

  60. Azadzoi KM, Master TA, Siroky MB. Effect of chronic ischemia on constitutive and inducible nitric oxide synthase expression in erectile tissue. J Androl. 2004;25:382–8.

    PubMed  CAS  Google Scholar 

  61. Sarteschi LM, Montorsi F, Menchini Fabris F, Guazzoni G, Lencioni R, Rigatti P. Cavernous arterial and arteriolar circulation in patients with erectile dysfunction: a power Doppler study. J Urol. 1998;159:428–32.

    PubMed  CAS  Google Scholar 

  62. Grein U, Schubert GE. Arteriosclerosis of penile arteries: histological findings and their significance in the treatment of erectile dysfunction. Urol Int. 2002;68:261–4.

    PubMed  Google Scholar 

  63. Nehra A, Azadzoi KM, Moreland RB, et al. Cavernosal expandability is an erectile tissue mechanical property which predicts trabecular histology in an animal model of vasculogenic erectile dysfunction. J Urol. 1998;159:2229–36.

    PubMed  CAS  Google Scholar 

  64. Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med. 1994;331:1286–92.

    PubMed  CAS  Google Scholar 

  65. Dugan LL, Quick KL. Reactive oxygen species and aging: evolving questions. Sci Aging Knowledge Environ. 2005;2005:pe20.

    PubMed  Google Scholar 

  66. Angelopoulou R, Lavranos G, Manolakou P. ROS in the aging male: model diseases with ROS-related pathophysiology. Reprod Toxicol. 2009;28:167–71.

    PubMed  CAS  Google Scholar 

  67. Rodríguez-Mañas L, El-Assar M, Vallejo S, et al. Endothelial dysfunction in aged humans is related with oxidative stress and vascular inflammation. Aging Cell. 2009;8:226–38.

    PubMed  Google Scholar 

  68. Jones RW, Rees RW, Minhas S, Ralph D, Persad RA, Jeremy JY. Oxygen free radicals and the penis. Expert Opin Pharmacother. 2002;3:889–97.

    PubMed  CAS  Google Scholar 

  69. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol. 1996;271:C1424–37.

    PubMed  CAS  Google Scholar 

  70. Zou M, Martin C, Ullrich V. Tyrosine nitration as a mechanism of selective inactivation of prostacyclin synthase by peroxynitrite. Biol Chem. 1997;378:707–13.

    PubMed  CAS  Google Scholar 

  71. Agarwal A, Nandipati KC, Sharma RK, Zippe CD, Raina R. Role of oxidative stress in the pathophysiological mechanism of erectile dysfunction. J Androl. 2006;27:335–47.

    PubMed  CAS  Google Scholar 

  72. Vardi Y, Dayan L, Apple B, Gruenwald I, Ofer Y, Jacob G. Penile and systemic endothelial function in men with and without erectile dysfunction. Eur Urol. 2009;55:979–85.

    PubMed  Google Scholar 

  73. Salonia A. Is ED still only equal to ED? Eur Urol. 2009;55:794–7.

    PubMed  Google Scholar 

  74. Corona G, Mannucci E, Fisher AD, et al. Low levels of androgens in men with erectile dysfunction and obesity. J Sex Med. 2008;5:2454–63.

    PubMed  CAS  Google Scholar 

  75. Shabsigh R, Arver S, Channer KS, et al. The triad of erectile dysfunction, hypogonadism and the metabolic syndrome. Int J Clin Pract. 2008;62:791–8.

    PubMed  CAS  Google Scholar 

  76. Zitzmann M. Testosterone deficiency, insulin resistance and the metabolic syndrome. Nat Rev Endocrinol. 2009;5:673–81.

    PubMed  CAS  Google Scholar 

  77. American Association of Clinical Endocrinologists. Medical guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients – 2002 update. Endocr Pract. 2002;8:440–56.

    Google Scholar 

  78. Araujo AB, O’Donnell AB, Brambilla DJ, et al. Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study. J Clin Endocrinol Metab. 2004;89:5920–6.

    PubMed  CAS  Google Scholar 

  79. Travison TG, Morley JE, Araujo AB, O’Donnell AB, McKinlay JB. The relationship between libido and testosterone levels in aging men. J Clin Endocrinol Metab. 2006;91:2509–13.

    PubMed  CAS  Google Scholar 

  80. Wang C, Nieschlag E, Swerdloff R, et al. Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations. Eur Urol. 2009;55:121–30.

    PubMed  Google Scholar 

  81. Feldman HA, Longcope C, Derby CA, et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts Male Aging Study. J Clin Endocrinol Metab. 2002;87:589–98.

    PubMed  CAS  Google Scholar 

  82. Isidori AM, Greco EA, Aversa A. Androgen deficiency and hormone-replacement therapy. BJU Int. 2005;96:212–6.

    PubMed  CAS  Google Scholar 

  83. Vermeulen A. Clinical review 24: androgens in the aging male. J Clin Endocrinol Metab. 1991;73:221–4.

    PubMed  CAS  Google Scholar 

  84. Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab. 2001;86:724–31.

    PubMed  CAS  Google Scholar 

  85. Morley JE, Kaiser FE, Perry III HM, et al. Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. Metabolism. 1997;46:410–3.

    PubMed  CAS  Google Scholar 

  86. Morales A, Buvat J, Gooren LJ, et al. Endocrine aspects of sexual dysfunction in men. J Sex Med. 2004;1:69–81.

    PubMed  CAS  Google Scholar 

  87. McClure RD. Endocrine investigation and therapy. Urol Clin North Am. 1987;14:471–88.

    PubMed  CAS  Google Scholar 

  88. Matsumoto AM, Bremner WJ. Serum testosterone essay – accuracy matters. J Clin Endocrinol Metab. 2004;89:520–4.

    PubMed  CAS  Google Scholar 

  89. Mohr BA, Guay AT, O’Donnell AB, McKinlay JB. Normal, bound and nonbound testosterone levels in normally ageing men: results from the Massachusetts Male Ageing Study. Clin Endocrinol (Oxf). 2005;62:64–73.

    CAS  Google Scholar 

  90. Chamness SL, Ricker DD, Crone JK, et al. The effect of androgen on nitric oxide synthase in the male reproductive tract of the rat. Fertil Steril. 1995;63:1101–7.

    PubMed  CAS  Google Scholar 

  91. Chou TM, Sudhir K, Hutchison SJ, et al. Testosterone induces dilation of canine coronary conductance and resistance arteries in vivo. Circulation. 1996;94:2614–9.

    PubMed  CAS  Google Scholar 

  92. Traish AM, Goldstein I, Kim NN. Testosterone and erectile function: from basic research to a new clinical paradigm for managing men with androgen insufficiency and erectile dysfunction. Eur Urol. 2007;52:54–70.

    PubMed  CAS  Google Scholar 

  93. Corona G, Maggi M. The role of testosterone in erectile dysfunction. Nat Rev Urol. 2010;7:46–56.

    PubMed  CAS  Google Scholar 

  94. Reilly CM, Stopper VS, Mills TM. Androgens modulate the alpha-adrenergic responsiveness of vascular smooth muscle in the corpus cavernosum. J Androl. 1997;18:26–31.

    PubMed  CAS  Google Scholar 

  95. Mills TM, Lewis RW, Stopper VS. Androgenic maintenance of inflow and veno-occlusion during erection in the rat. Biol Reprod. 1998;59:1413–8.

    PubMed  CAS  Google Scholar 

  96. Mitchell JB, Stewart J. Effects of castration, steroid replacement, and sexual experience on mesolimbic dopamine and sexual behaviors in the male rat. Brain Res. 1989;491:116–27.

    PubMed  CAS  Google Scholar 

  97. Bagatell CJ, Heiman JR, Rivier JE, Bremner WJ. Effects of endogenous testosterone and estradiol on sexual behavior in normal young men. J Clin Endocrinol Metab. 1994;78:711–6.

    PubMed  CAS  Google Scholar 

  98. Corona G, Petrone L, Fisher AD, et al. Six-month administration of 1% testosterone gel is able to restore erectile function in hypogonadal patients with erectile dysfunction. Arch Ital Urol Androl. 2008;80:103–8.

    PubMed  Google Scholar 

  99. Chiang HS, Cho SL, Lin YC, Hwang TI. Testosterone gel monotherapy improves sexual function of hypogonadal men mainly through restoring erection: evaluation by IIEF score. Urology. 2009;73:762–6.

    PubMed  Google Scholar 

  100. Shabsigh R, Rajfer J, Aversa A, et al. The evolving role of testosterone in the treatment of erectile dysfunction. Int J Clin Pract. 2006;60:1087–92.

    PubMed  CAS  Google Scholar 

  101. Wang C, Swerdloff R, Kipnes M, et al. New testosterone buccal system (Striant) delivers physiological testosterone levels: pharmacokinetics study in hypogonadal men. J Clin Endocrinol Metab. 2004;89:3821–9.

    PubMed  CAS  Google Scholar 

  102. Shabsigh R, Kaufman JM, Steidle C, Padma-Nathan H. Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone. J Urol. 2008;179 Suppl 5:S97–102.

    PubMed  CAS  Google Scholar 

  103. Mulhall JP. Treatment of erectile dysfunction in a hypogonadal male. Rev Urol. 2004;6 Suppl 6:S38–40.

    PubMed  Google Scholar 

  104. Rosenthal BD, May NR, Metro MJ, Harkaway RC, Ginsberg PC. Adjunctive use of AndroGel (testosterone gel) with sildenafil to treat erectile dysfunction in men with acquired androgen deficiency syndrome after failure using sildenafil alone. Urology. 2006;67:571–4.

    PubMed  Google Scholar 

  105. Hwang TI, Chen HE, Tsai TF, Lin YC. Combined use of androgen and sildenafil for hypogonadal patients unresponsive to sildenafil alone. Int J Impot Res. 2006;18:400–4.

    PubMed  CAS  Google Scholar 

  106. Zhang XH, Morelli A, Luconi M. Testosterone regulates PDE5 expression and in vivo responsiveness to tadalafil in rat corpus cavernosum. Eur Urol. 2005;47:409–16.

    PubMed  CAS  Google Scholar 

  107. Aversa A, Isidori AM, Spera G, Lenzi A, Fabbri A. Androgens improve cavernous vasodilation and response to sildenafil in patients with erectile dysfunction. Clin Endocrinol (Oxf). 2003;58:632–8.

    CAS  Google Scholar 

  108. Kaminetsky J. Epidemiology and pathophysiology of male sexual dysfunction. Int J Impot Res. 2008;20:3–10.

    Google Scholar 

  109. Frajese G, Lazzari R, Magnani A, Moretti C, Sforza V, Nerozzi D. Neurotransmitter, opiodergic system, steroid–hormone interaction and involvement in the replacement therapy of sexual disorders. J Steroid Biochem Mol Biol. 1990;37:411–9.

    PubMed  CAS  Google Scholar 

  110. Verhelst J, Abs R. Hyperprolactinemia: pathophysiology and management. Treat Endocrinol. 2003;2:23–32.

    PubMed  Google Scholar 

  111. Buvat J. Hyperprolactinemia and sexual function in men: a short review. Int J Impot Res. 2003;15:373–7.

    PubMed  CAS  Google Scholar 

  112. Lue T. Erectile dysfunction. N Eng J Med. 2000;342:1802–13.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Vita-Salute San Raffaele University, Via Olgettina 60, 20132, Milan, Italy

    Antonino Saccà

Authors
  1. Antonino Saccà
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Francesco Montorsi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Antonino Saccà .

Editor information

Editors and Affiliations

  1. Sexual Medicine Program, Memorial Sloan-Kettering Cancer Center, East 68th Street 353, New York, 10021, New York, USA

    John P. Mulhall

  2. Daniel den Hoed Cancer Center, Dept. Radiation Oncology, Erasmus Medical Center, Groene Hilledijk 301, Rotterdam, 3075 EA, Netherlands

    Luca Incrocci

  3. Alvarado Hospital, Alvarado Road 6719, San Diego, 92120, California, USA

    Irwin Goldstein

  4. New England Research Institutes, Galen Street 9, Watertown, 02472, Massachusetts, USA

    Ray Rosen

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Saccà, A., Montorsi, F. (2011). Erectile Dysfunction: Prevalence and Pathophysiology. In: Mulhall, J., Incrocci, L., Goldstein, I., Rosen, R. (eds) Cancer and Sexual Health. Current Clinical Urology. Humana Press. https://doi.org/10.1007/978-1-60761-916-1_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-60761-916-1_13

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-60761-915-4

  • Online ISBN: 978-1-60761-916-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation